ATA694274A - Verfahren zur herstellung von n- (2-furfuryl)-4-chlor-5-sulfamoyl-anthranilsaure-zubereitungen - Google Patents

Verfahren zur herstellung von n- (2-furfuryl)-4-chlor-5-sulfamoyl-anthranilsaure-zubereitungen

Info

Publication number
ATA694274A
ATA694274A AT694274A AT694274A ATA694274A AT A694274 A ATA694274 A AT A694274A AT 694274 A AT694274 A AT 694274A AT 694274 A AT694274 A AT 694274A AT A694274 A ATA694274 A AT A694274A
Authority
AT
Austria
Prior art keywords
sulphamoyl
furfuryl
chlorine
preparation
anthranilic acid
Prior art date
Application number
AT694274A
Other languages
English (en)
Other versions
AT344914B (de
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5890849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATA694274(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ATA694274A publication Critical patent/ATA694274A/de
Application granted granted Critical
Publication of AT344914B publication Critical patent/AT344914B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT694274A 1973-08-28 1974-08-27 Verfahren zur herstellung von n- (2-furfuryl)-4-chlor-5-sulfamoyl-anthranilsaeure-zubereitungen AT344914B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2343218A DE2343218C2 (de) 1973-08-28 1973-08-28 Furosemid enthaltende Pellets

Publications (2)

Publication Number Publication Date
ATA694274A true ATA694274A (de) 1977-12-15
AT344914B AT344914B (de) 1978-08-25

Family

ID=5890849

Family Applications (1)

Application Number Title Priority Date Filing Date
AT694274A AT344914B (de) 1973-08-28 1974-08-27 Verfahren zur herstellung von n- (2-furfuryl)-4-chlor-5-sulfamoyl-anthranilsaeure-zubereitungen

Country Status (17)

Country Link
US (1) US4324779A (de)
JP (1) JPS563849B2 (de)
AT (1) AT344914B (de)
BE (1) BE819294A (de)
CA (1) CA1063024A (de)
DE (1) DE2343218C2 (de)
DK (1) DK155173B (de)
EG (1) EG14662A (de)
FI (1) FI249774A (de)
FR (1) FR2242076B1 (de)
GB (1) GB1478715A (de)
HU (1) HU171769B (de)
IL (1) IL45521A (de)
MX (1) MX3585E (de)
NL (1) NL7411269A (de)
SE (1) SE7410788L (de)
ZA (1) ZA745443B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1544761A (en) * 1976-11-26 1979-04-25 Pennwalt Corp Prolonged release pharmaceutical preparations
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4773907A (en) * 1982-12-20 1988-09-27 Alza Corporation Primary delivery system comprising secondary dosage form
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
DE3305935C2 (de) * 1983-02-21 1985-05-30 Medice Chem.-Pharm. Fabrik Pütter GmbH & Co KG, 5860 Iserlohn Kaliumneutrales Saluretikum mit antihypertensiver Wirkung
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
US4663348A (en) * 1985-07-02 1987-05-05 Warner-Lambert Co. Furosemide salts and pharmaceutical preparations thereof
SE460947B (sv) * 1986-08-26 1989-12-11 Lejus Medical Ab En multiple-unit-dos komposition av l-dopa
JPH01130957U (de) * 1988-02-29 1989-09-06
JPH0710747A (ja) * 1993-04-28 1995-01-13 Takeda Chem Ind Ltd 固形製剤およびその製造方法
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
US20070059358A1 (en) * 2003-07-02 2007-03-15 Tianjin Tasly Pharmaceutical Co., Ltd., China Matrix adjuvants and the drop pills prepared with them

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058882A (en) * 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
US3361632A (en) * 1964-05-08 1968-01-02 Hoechst Ag Medicinal preparations having a protracted activity and method of making them
US3456049A (en) * 1965-05-25 1969-07-15 Ciba Geigy Corp Gradual-release tablet
US3857933A (en) * 1969-10-17 1974-12-31 Hoechst Ag Process for the manufacture of a drug dosage form permitting controlled release of active ingredient
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung

Also Published As

Publication number Publication date
GB1478715A (en) 1977-07-06
DK455274A (de) 1975-04-28
MX3585E (es) 1981-03-20
FI249774A (de) 1975-03-01
ZA745443B (en) 1975-08-27
AU7272874A (en) 1976-03-04
SE7410788L (de) 1975-03-03
IL45521A0 (en) 1974-11-29
IL45521A (en) 1978-07-31
DE2343218A1 (de) 1975-04-03
FR2242076B1 (de) 1978-07-28
US4324779A (en) 1982-04-13
AT344914B (de) 1978-08-25
FR2242076A1 (de) 1975-03-28
DE2343218C2 (de) 1986-08-07
NL7411269A (nl) 1975-03-04
HU171769B (hu) 1978-03-28
BE819294A (fr) 1975-02-28
JPS563849B2 (de) 1981-01-27
EG14662A (en) 1984-09-30
CA1063024A (en) 1979-09-25
DK155173B (da) 1989-02-27
JPS5076217A (de) 1975-06-21

Similar Documents

Publication Publication Date Title
AT333726B (de) Verfahren zur herstellung von neuen n-cinnamoyl- oder hydrocinnamoylaminobenzoesauren
ATA839174A (de) Verfahren zur herstellung von optisch aktiven alfa-n-acylamino-propionsauren
AT343294B (de) Verfahren zur herstellung von 25-hydroxycholesterin
DD127730A5 (de) Verfahren zur herstellung von 7-d-(-)-alpha-amino-alpha-(p-hydroxyphenylacetamido)desacetoxycephalosporansaeure
ATA694274A (de) Verfahren zur herstellung von n- (2-furfuryl)-4-chlor-5-sulfamoyl-anthranilsaure-zubereitungen
AT338760B (de) Verfahren zur herstellung von 3-amino-5-sulfamylbenzoesaurederivaten
AT344154B (de) Verfahren zur herstellung von 5-fluor-2-methyl-1- (p-methylsulfinylbenzyliden)-indenyl-3-essigsaeure
AT338774B (de) Verfahren zur herstellung von 5-fluor-2-methyl-1-(p-methylsulfinylbenzyliden)-inden-3-essigsaure und ihren saureadditionssalzen
AT332861B (de) Verfahren zur herstellung von 2-chlor-5-aminosulfonylbenzoesauren
AT331393B (de) Verfahren zur herstellung von 7-amino-desacetoxycephalosporansaure
ATA1092972A (de) Verfahren zur herstellung von 7-acylamino-3-substituierten-3-cephem-4-carbonsaurederivate
AT319931B (de) Verfahren zur Herstellung von N-(1-Äthyl-α-pyrrolidylmethyl)-2-methoxy-5-sulfamidobenzamid
CH550205A (de) Verfahren zur herstellung von n-(aminomethyliden)-thiolphosphorsaeureesterimiden.
AT339286B (de) Verfahren zur herstellung von n-(diathylaminoathyl)-2-methoxy-4-amino-5-chlorbenzamid
AT339303B (de) Verfahren zur herstellung von hydroxymethylpyridinen
ATA144774A (de) Verfahren zur herstellung von 4-hydroxy-thiochromanen
AT329178B (de) Verfahren zur herstellung von 6-aminopenicillansaurederivaten
DD107018A2 (de) Verfahren zur herstellung von 2-imino-oxazolin-derivaten
AT338766B (de) Verfahren zur herstellung von n-(diathylaminoathyl)-2-methoxy-4-amino-5-chlorbenzamid
AT338972B (de) Verfahren zur herstellung von 7-alfa-aminoacetamidocephalosporin-4-carbonsauren
ATA159574A (de) Verfahren zur herstellung von n- (diathylaminoathyl)-2-methoxy-4-amino-5-chlorbenzamid
AT331780B (de) Verfahren zur herstellung von neuen 3-n-butylamino-4-phenoxy-5-alkoxymethyl-sulfamoylbenzoesauren
ATA944274A (de) Verfahren zur herstellung von desacetoxycephalosporin c
AT344905B (de) Verfahren zur herstellung von 6-aminopenicillansaeure
AT334395B (de) Verfahren zur herstellung von n-phosphonomethylglycinen

Legal Events

Date Code Title Description
ELA Expired due to lapse of time